Portfolio company Samphire Neuroscience closed a $5M seed round led by Inventure following FIRSTPICK's first institutional check.
Added recently
Samphire Neuroscience develops a medical-grade headband to manage mood and pain linked to hormonal changes
Samphire Neuroscience develops a medical-grade headband to manage mood and pain linked to hormonal changes. The device uses neurostimulation and is backed by clinical trials. It's available for consultation in the US.